obesity drug news today glp-1 october 23 2025 New oral drugs could offer more options for weight loss GLP-1 Agonists Market Report 2025-2033,
Description
doi: 10.3390/cells9071687 68 BartelsALWillemsenATDoorduinJde VriesEFDierckxRALeendersKL
Curr Obes Rep 11 , 263276 (2022)
Psychiatry 26 , 43944408 (2021)
That, combined with possible nutritional deficiencies from eating less, could lead to shedding
52-WEEK RESULTS Statistically significant A1C reduction vs Januvia 2,4* A1C reduction demonstrated at 52 weeks ETD=estimated treatment difference
[DOI] [PubMed] [Google Scholar] 39.Thim L., Moody A.J
